WallStreetZenWallStreetZen

NASDAQ: IPHA
Innate Pharma Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IPHA

Based on 1 analyst offering 12 month price targets for Innate Pharma Sa.
Min Forecast
$11.50+345.74%
Avg Forecast
$11.50+345.74%
Max Forecast
$11.50+345.74%

Should I buy or sell IPHA stock?

Based on 1 analyst offering ratings for Innate Pharma Sa.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IPHA stock forecasts and price targets.

IPHA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$11.50+345.74%2023-09-18

1 of 1

Forecast return on equity

Is IPHA forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.73%

Forecast return on assets

Is IPHA forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.11%

IPHA revenue growth forecast

How is IPHA forecast to perform vs Biotechnology companies and vs the US market?
Company
41.76%
Industry
34.63%
Market
8.12%
IPHA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IPHA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IPHA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IPHA$2.58$11.50+345.74%Buy
GRCL$3.05$16.00+424.59%Strong Buy
LCTX$1.19$6.50+446.22%Strong Buy
FATE$2.10$6.30+200.00%Buy
SLNO$20.67$24.50+18.53%Strong Buy
View Top Biotech Stocks

Innate Pharma Sa Stock Forecast FAQ

Is Innate Pharma Sa Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IPHA) stock is to Buy IPHA stock.

Out of 1 analyst, 0 (0%) are recommending IPHA as a Strong Buy, 1 (100%) are recommending IPHA as a Buy, 0 (0%) are recommending IPHA as a Hold, 0 (0%) are recommending IPHA as a Sell, and 0 (0%) are recommending IPHA as a Strong Sell.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.

What is IPHA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: IPHA) forecast ROE is N/A, which is considered weak.

What is IPHA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IPHA price target, the average IPHA price target is $11.50, with the highest IPHA stock price forecast at $11.50 and the lowest IPHA stock price forecast at $11.50.

The Wall Street analyst predicted that Innate Pharma Sa's share price could reach $11.50 by Sep 18, 2024. The average Innate Pharma Sa stock price prediction forecasts a potential upside of 345.74% from the current IPHA share price of $2.58.

What is IPHA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: IPHA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.